These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16204267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.
    N Engl J Med; 2005 Feb 17; 352(7):666-75. PubMed ID: 15716560
    [Abstract] [Full Text] [Related]

  • 3. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.
    Am J Cardiol; 2006 Jul 01; 98(1):111-5. PubMed ID: 16784932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I.
    Shock; 2009 Apr 01; 31(4):342-7. PubMed ID: 18791494
    [Abstract] [Full Text] [Related]

  • 6. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B, Zeller M, Desgrès J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y.
    Eur Heart J; 2005 Sep 01; 26(17):1734-41. PubMed ID: 15831555
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP, Ryan JE, van Gaal WJ, Lam QT, Sinnappu RN, Burrell LM, Savige J, Lim WK.
    Am J Cardiol; 2010 Sep 15; 106(6):865-72. PubMed ID: 20816130
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 10. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.
    Crit Care Med; 2007 Oct 15; 35(10):2268-73. PubMed ID: 17717488
    [Abstract] [Full Text] [Related]

  • 11. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.
    Ballotta A, Ranucci M, Kunkl A, El Baghdady H, Bossone E, Castelvecchio S, Frigiola A, Menicanti L, Di Donato M, Mehta RH.
    Am J Cardiol; 2010 Mar 01; 105(5):640-4. PubMed ID: 20185010
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D, van Kuijk JP, Flu WJ, Hoeks SE, Chonchol M, Verhagen HJ, Bax JJ, Poldermans D.
    Am J Cardiol; 2011 Feb 15; 107(4):609-14. PubMed ID: 21185000
    [Abstract] [Full Text] [Related]

  • 14. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 15. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S, LIPID Study Investigators.
    Eur Heart J; 2008 Apr 15; 29(7):923-31. PubMed ID: 18296678
    [Abstract] [Full Text] [Related]

  • 16. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A.
    Crit Care Med; 2009 Jun 15; 37(6):1837-44. PubMed ID: 19384228
    [Abstract] [Full Text] [Related]

  • 17. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.
    Am J Cardiol; 2008 Jan 01; 101(1):122-6. PubMed ID: 18157978
    [Abstract] [Full Text] [Related]

  • 18. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ, Zareba W, Bisognano JD.
    Am J Cardiol; 2007 Apr 15; 99(8):1143-5. PubMed ID: 17437744
    [Abstract] [Full Text] [Related]

  • 19. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.
    Am J Cardiol; 2009 Aug 15; 104(4):559-64. PubMed ID: 19660612
    [Abstract] [Full Text] [Related]

  • 20. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.
    Am J Cardiol; 2006 Aug 15; 98(4):525-9. PubMed ID: 16893710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.